Lori A Leslie (Lori Leslie)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Ejection Fraction

Multiple Myeloma

Prognostic Factors

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Jason R Westin, Frederick L Locke, Michael J Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David Bernard Miklos, Matthew L Ulrickson, Miguel-Ángel Perales, Umar Farooq, Luciano Wannesson, Lori A Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Georg Wulf, Patrick B Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O Oluwole, Anna Sureda
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lori A Leslie, Nilesh Gangan, Hiangkiat Tan, Qing Huang
Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia. Current medical research and opinion 38 (12) (2022)
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A Reeves, Wanda Knopińska-Posłuszny, Chan Yoon Y Cheah, Tycel Jovelle Phillips, Ewa Lech-Maranda, Bruce D Cheson, Paolo F Caimi, Sebastian Grosicki, Lori A Leslie, Julio C Chavez, Gustavo Fonseca, Sunil Babu, Daniel James Hodson, Spencer H Shao, John M Burke, Jeff P Sharman, Jennie Y Law, John M Pagel, Hari P Miskin, Peter Sportelli, Owen A O'Connor, Michael S Weiss, Pier Luigi Luigi Zinzani
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)